Division of Cardiac Electrophysiology, Geisinger Heart Institute, MC 36-10, 1000 E Mountain Blvd, Wilkes-Barre, PA, 18711, USA.
Curr Cardiol Rep. 2018 Sep 26;20(11):109. doi: 10.1007/s11886-018-1046-z.
Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) is the cornerstone of treatment for patients with heart failure and left bundle branch block. Up to a third of patients do not respond to BVP. This article reviews the utility of His-bundle pacing (HBP) and Left ventricular (LV) endocardial pacing as alternatives to BVP to provide ventricular synchrony.
HBP has shown promising results in observational studies. By significantly narrowing or normalizing QRS, HBP has improved clinical outcomes including ejection fractions both as a rescue option in patients who failed BVP or as a primary alternative. LV endocardial pacing has also shown promise with improved clinical outcomes. Using traditional pacing leads or novel technology, direct stimulation of the LV endocardium allows for better site selection as well as a more physiological activation of the LV compared to traditional epicardial LV stimulation. HBP and LV endocardial pacing are valuable alternatives to traditional BVP to achieve CRT. Randomized clinical trials in progress will allow for a deeper understanding of how they can benefit our patients.
心脏再同步治疗(CRT)采用双心室起搏(BVP)是心力衰竭伴左束支传导阻滞患者治疗的基石。多达三分之一的患者对 BVP 无反应。本文综述希氏束起搏(HBP)和左心室(LV)心内膜起搏作为替代 BVP 以提供心室同步性的方法。
HBP 在观察性研究中显示出良好的效果。通过显著缩小或正常化 QRS,HBP 改善了临床结果,包括射血分数,作为 BVP 失败患者的抢救选择或作为主要替代方案。LV 心内膜起搏也显示出良好的临床效果。使用传统起搏导线或新技术,直接刺激 LV 心内膜可以更好地选择部位,并与传统的心外膜 LV 刺激相比,更生理性地激活 LV。HBP 和 LV 心内膜起搏是传统 BVP 实现 CRT 的有价值的替代方法。正在进行的随机临床试验将使我们更深入地了解它们如何使我们的患者受益。